SE402709B - Forfarande for framstellning av ett farmaceutiskt preparat for behandling av hyperkolesterolemi, innehallande p-klorfenoxiisosmorsyra eller vissa estrar eller salter derav - Google Patents
Forfarande for framstellning av ett farmaceutiskt preparat for behandling av hyperkolesterolemi, innehallande p-klorfenoxiisosmorsyra eller vissa estrar eller salter deravInfo
- Publication number
- SE402709B SE402709B SE7113008A SE1300871A SE402709B SE 402709 B SE402709 B SE 402709B SE 7113008 A SE7113008 A SE 7113008A SE 1300871 A SE1300871 A SE 1300871A SE 402709 B SE402709 B SE 402709B
- Authority
- SE
- Sweden
- Prior art keywords
- preparation
- hypercolesterolemia
- estrars
- chlorophenoxiisosmoroic
- salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4914070 | 1970-10-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE402709B true SE402709B (sv) | 1978-07-17 |
Family
ID=10451313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7113008A SE402709B (sv) | 1970-10-15 | 1971-10-14 | Forfarande for framstellning av ett farmaceutiskt preparat for behandling av hyperkolesterolemi, innehallande p-klorfenoxiisosmorsyra eller vissa estrar eller salter derav |
Country Status (7)
Country | Link |
---|---|
US (1) | US3846541A (sv) |
AU (1) | AU458705B2 (sv) |
CA (1) | CA968272A (sv) |
DE (1) | DE2151510A1 (sv) |
FR (1) | FR2110458B1 (sv) |
GB (1) | GB1348642A (sv) |
SE (1) | SE402709B (sv) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069306A (en) * | 1974-03-14 | 1978-01-17 | Pharmacia Aktiebolag | X-ray contrast preparation containing a hydrophilic polymer containing amino groups |
FR2382892A1 (fr) * | 1977-03-08 | 1978-10-06 | Sarget Lab | Nouveau medicament hypolipidemiant a base d'ester de p-chlorophenol de l'acide p-chlorophenoxyisobutyrique |
IT1106718B (it) | 1978-12-21 | 1985-11-18 | Alfa Farmaceutici Spa | Composizioni a base di resine anioniche salificate farmacologicamente attive |
US4393145A (en) * | 1979-05-01 | 1983-07-12 | Etablissement Texcontor | Anionic ion exchange resins with cholesterol-decreasing properties |
US4788055A (en) * | 1985-12-09 | 1988-11-29 | Ciba-Geigy Corporation | Resinate sustained release dextromethorphan composition |
EP0276807A3 (en) * | 1987-01-27 | 1988-10-12 | Warner-Lambert Company | Lipid regulating compositions |
US5167965A (en) * | 1987-02-09 | 1992-12-01 | The Dow Chemical Company | Palatable cholestyramine granules, tablets and methods for preparation thereof |
IL85632A (en) * | 1987-03-10 | 1991-08-16 | Ciba Geigy Ag | Hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin |
US4837255A (en) * | 1987-03-10 | 1989-06-06 | Ciba-Geigy Corporation | Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin |
US4859703A (en) * | 1987-06-15 | 1989-08-22 | Warner-Lambert Company | Lipid regulating compositions |
US5520932A (en) * | 1988-06-24 | 1996-05-28 | The Upjohn Company | Fine-milled colestipol hydrochloride |
IL95574A (en) * | 1989-09-09 | 1994-11-11 | Knoll Ag | Colstiramine preparation |
US8178516B2 (en) * | 1992-06-30 | 2012-05-15 | Sylvan Labs, LLC | Compositions and method for treatment of chronic inflammatory diseases |
US20050090553A1 (en) * | 1992-06-30 | 2005-04-28 | Shapiro Howard K. | Compositions and method for treatment of chronic inflammatory diseases |
US5451397A (en) * | 1992-12-21 | 1995-09-19 | Rohm And Haas Company | Bile acid sequestrant |
US5498678A (en) * | 1992-12-21 | 1996-03-12 | Rohm And Haas Company | Suspension polymerization process for water-soluble monomers |
US7071174B1 (en) * | 1994-10-13 | 2006-07-04 | Cv Therapeutics, Inc. | Method and composition for inhibiting cholesterol esterase |
CN103228270B (zh) | 2010-11-08 | 2016-02-10 | 阿尔比里奥公司 | 含ibat抑制剂和胆汁酸结合剂的药物组合 |
RU2591188C2 (ru) | 2010-11-08 | 2016-07-10 | Альбирео Аб | Ингибиторы ibat для лечения заболеваний печени |
ES2782523T3 (es) * | 2011-08-01 | 2020-09-15 | Hb Biotechnologies Corp | Cápsulas no digeribles para la administración de materiales absorbentes de líquido |
CN107375291A (zh) | 2011-10-28 | 2017-11-24 | 鲁美纳医药公司 | 用于治疗高胆血症和胆汁淤积性肝病的胆汁酸再循环抑制剂 |
MX354242B (es) | 2011-10-28 | 2018-02-20 | Lumena Pharmaceuticals Inc | Nhibidores de la recirculación de ácidos biliares para el tratamiento de enfermedades hepáticas colestásicas pediátricas. |
MX2015013193A (es) | 2013-03-15 | 2016-04-15 | Lumena Pharmaceuticals Inc | Inhibidores del reciclaje de acidos biliares para el tratamiento de colangitis esclerosante primaria y enfermedad inflamatoria intestinal. |
JP2016514678A (ja) | 2013-03-15 | 2016-05-23 | ルメナ ファーマシューティカルズ エルエルシー | バレット食道と胃食道逆流性疾患を処置するための胆汁酸再利用阻害剤 |
JP2022519905A (ja) | 2019-02-12 | 2022-03-25 | ミルム ファーマシューティカルズ インコーポレイテッド | 胆汁酸塩排出ポンプ欠損症の患者における遺伝子型およびasbtiに対する用量依存的反応 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB860303A (en) * | 1958-06-20 | 1961-02-01 | Ici Ltd | Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª |
US3042667A (en) * | 1959-03-10 | 1962-07-03 | Pharmacia Ab | Process for producing dextran derivatives and products resulting therefrom |
NL126243C (sv) * | 1959-06-12 | |||
US3308020A (en) * | 1961-09-22 | 1967-03-07 | Merck & Co Inc | Compositions and method for binding bile acids in vivo including hypocholesteremics |
US3383281A (en) * | 1961-09-22 | 1968-05-14 | Merck & Co Inc | Method for binding bile acids in vivo |
US3627872A (en) * | 1968-04-08 | 1971-12-14 | Upjohn Co | Oral treatment of hyper-cholesteremia in mammals and birds with ether-type anion exchangers of polysaccharides |
-
1970
- 1970-10-15 GB GB4914070A patent/GB1348642A/en not_active Expired
-
1971
- 1971-10-13 AU AU34513/71A patent/AU458705B2/en not_active Expired
- 1971-10-13 CA CA125,078A patent/CA968272A/en not_active Expired
- 1971-10-14 SE SE7113008A patent/SE402709B/sv unknown
- 1971-10-15 FR FR7137143A patent/FR2110458B1/fr not_active Expired
- 1971-10-15 DE DE19712151510 patent/DE2151510A1/de active Pending
-
1973
- 1973-03-20 US US00343182A patent/US3846541A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU458705B2 (en) | 1975-03-06 |
CA968272A (en) | 1975-05-27 |
FR2110458B1 (sv) | 1975-02-07 |
GB1348642A (en) | 1974-03-20 |
FR2110458A1 (sv) | 1972-06-02 |
AU3451371A (en) | 1973-04-19 |
US3846541A (en) | 1974-11-05 |
DE2151510A1 (de) | 1972-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE402709B (sv) | Forfarande for framstellning av ett farmaceutiskt preparat for behandling av hyperkolesterolemi, innehallande p-klorfenoxiisosmorsyra eller vissa estrar eller salter derav | |
SE385585B (sv) | Forfarande for framstellning av 1-alkyl-1,4-dihydro-4-oxo-3-kinolinkarboxylsyraderivat | |
NO145883C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7-methoxy-7-acylamino-cefalosporansyrederivater | |
DK124547B (da) | Analogifremgangsmåde til fremstilling af (3-amino-2-hydroxy-propyloxy)-thiochromanderivater eller syreadditionssalte deraf. | |
SE373371B (sv) | Forfarande for framstellning av 1-aminoalken-1,1-difosfonsyror eller salter derav | |
SE425392B (sv) | Forfarande for framstellning av nya 5,9-beta-disubstituerade 2-tetrahydrofurfuryl-6,7-bensomorfaner eller deras syraadditionssalter | |
SE400296B (sv) | Forfarande for framstellning av derivat av cyklisk adenosin-3',5'-monofosforsyra | |
SE405121B (sv) | Forfarande for framstellning av 2-(heteroaryl-metyl)-5-9beta-dialkyl-6,7-bensomorfaner eller deras syraadditionssalter | |
SE398229B (sv) | Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat | |
SE385118B (sv) | Forfarande for framstellning av 2-(6-metoxi-2-naftyl)-propionsyra | |
NO143575C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater | |
SE409460B (sv) | Forfarande for framstellnoing av farmaceutiskt godtagbara syraadditionssalter av aminoglykosidantibiotika | |
SE396011B (sv) | Forfarande for framstellning av en i huvudsak klar, steril vattenlosning av 1,3-bis(2-karboxikromon-5-yloxi)-propan-2-ol eller ett farmaceutiskt godtagbart salt derav | |
NO146241C (no) | Fremgangsmaate til fremstilling av hetacephalexin eller salter derav | |
NO153299C (no) | Fremgangsmaate for fremstilling av 6-d-alfa-amino-alfa-(p-hydroksy-fenyl)-acetamido-penicillansyre eller salter derav. | |
SE400551B (sv) | Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat | |
SE416729B (sv) | Forfarande for framstellning av salter av p-dihydroxibensendisulfonsyra | |
DK131778B (da) | Fremgangsmåde til fremstilling af substituerede 3-hydroksymetylisokinolinderivater eller syreadditionssalte heraf. | |
SE402009B (sv) | Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat | |
SE393801B (sv) | Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken | |
DK131857B (da) | Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater eller syreadditionssalte deraf. | |
DK138943B (da) | Analogifremgangsmåde til fremstilling af substituerede dibenzocyclohepten-carboxamider eller syreadditionssalte deraf. | |
DK137044B (da) | Analogifremgangsmåde til fremstilling af 4,4-diphenylhexahydroazepinderivater eller syreadditionssalte deraf. | |
SE431216B (sv) | Forfarande for framstellning av 1n-(alfa-hydroxi-omega-amino-alkanoyl)-6 721n-metyl-3 721, 4 721-dideoxikanamycin b eller farmaceutiskt godtagbara syraadditionssalter derav | |
DK138540B (da) | Analogifremgangsmåde til fremstilling af benzhydryloxyalkylaminderivater eller farmaceutisk acceptable syreadditionssalte deraf. |